(BCS) Barclays - Ratings and Ratios

Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US06738E2046

Retail Banking, Credit Cards, Investment Banking, Wealth Management

BCS EPS (Earnings per Share)

EPS (Earnings per Share) of BCS over the last years for every Quarter: "2020-09-30": 0.2035, "2020-12-31": 0.0725, "2021-03-31": 0.5483, "2021-06-30": 0.6824, "2021-09-30": 0.4699, "2021-12-31": 0.358, "2022-03-31": 0.418, "2022-06-30": 0.3105, "2022-09-30": 0.4279, "2022-12-31": 0.3121, "2023-03-31": 0.6439, "2023-06-30": 0.442, "2023-09-30": 0.4043, "2023-12-31": 0.21, "2024-03-31": 0.58, "2024-06-30": 0.41, "2024-09-30": 0.56, "2024-12-31": 0.21, "2025-03-31": 0.656, "2025-06-30": 0.63,

BCS Revenue

Revenue of BCS over the last years for every Quarter: 2020-09-30: 4583, 2020-12-31: 4790, 2021-03-31: 5900, 2021-06-30: 6211, 2021-09-30: 5465, 2021-12-31: 5160, 2022-03-31: 6355, 2022-06-30: 6508, 2022-09-30: 5951, 2022-12-31: 5792, 2023-03-31: 6713, 2023-06-30: 5913, 2023-09-30: 6258, 2023-12-31: 5604, 2024-03-31: 6953, 2024-06-30: 18838, 2024-09-30: 6547, 2024-12-31: 19282, 2025-03-31: 7709, 2025-06-30: 18429,

Description: BCS Barclays

Barclays PLC is a diversified banking institution with a global presence, operating in multiple regions including the UK, Europe, the Americas, Africa, the Middle East, and Asia. The companys diversified business model is reflected in its various segments, including retail banking, corporate banking, private banking, investment banking, and consumer banking.

From a financial perspective, Barclays PLC has a market capitalization of approximately $64.6 billion USD, indicating a significant presence in the global financial landscape. The companys price-to-earnings ratio (P/E) is around 8.86, suggesting that its stock may be undervalued relative to its earnings. Additionally, the forward P/E ratio is 7.92, implying potential for future earnings growth. The return on equity (RoE) is 8.78%, indicating a reasonable level of profitability.

Key performance indicators (KPIs) that can be used to evaluate Barclays PLCs performance include its net interest margin (NIM), which measures the difference between interest income and expense; its cost-to-income ratio, which assesses operational efficiency; and its capital adequacy ratio, which evaluates the banks capital strength. Other relevant KPIs include the banks loan-to-deposit ratio, which measures liquidity, and its asset quality metrics, such as non-performing loan ratios.

From a technical analysis perspective, the support levels for Barclays PLCs stock (BCS) are identified at $13.3, $12.7, $11.7, and $10.4, indicating potential areas of buying interest. The stocks current price is $18.48, with a 52-week high of $18.81 and a low of $10.27, suggesting a relatively stable trading range over the past year.

BCS Stock Overview

Market Cap in USD 71,174m
Sub-Industry Diversified Banks
IPO / Inception 1986-09-10

BCS Stock Ratings

Growth Rating 90.9%
Fundamental 51.9%
Dividend Rating 64.6%
Return 12m vs S&P 500 50.5%
Analyst Rating 4.0 of 5

BCS Dividends

Dividend Yield 12m 2.43%
Yield on Cost 5y 10.26%
Annual Growth 5y 6.18%
Payout Consistency 89.1%
Payout Ratio 21.1%

BCS Growth Ratios

Growth Correlation 3m 91.4%
Growth Correlation 12m 96.7%
Growth Correlation 5y 59.9%
CAGR 5y 44.15%
CAGR/Max DD 3y 1.47
CAGR/Mean DD 3y 9.98
Sharpe Ratio 12m 2.56
Alpha 0.00
Beta 0.851
Volatility 27.94%
Current Volume 7275.2k
Average Volume 20d 8558.8k
Stop Loss 20 (-3.1%)
Signal -0.66

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (7.02b TTM) > 0 and > 6% of Revenue (6% = 3.12b TTM)
FCFTA 0.00 (>2.0%) and ΔFCFTA 0.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -785.3% (prev -454.9%; Δ -330.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.02 (>3.0%) and CFO 27.41b > Net Income 7.02b (YES >=105%, WARN >=100%)
Net Debt (-108.28b) to EBITDA (8.13b) ratio: -13.32 <= 3.0 (WARN <= 3.5)
Current Ratio 0.36 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (3.58b) change vs 12m ago -9.70% (target <= -2.0% for YES)
Gross Margin 51.14% (prev 40.60%; Δ 10.54pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 3.27% (prev 2.39%; Δ 0.88pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.08 (EBITDA TTM 8.13b / Interest Expense TTM 25.39b) >= 6 (WARN >= 3)

Altman Z'' -1.51

(A) -0.26 = (Total Current Assets 225.72b - Total Current Liabilities 633.84b) / Total Assets 1598.70b
(B) 0.04 = Retained Earnings (Balance) 57.75b / Total Assets 1598.70b
(C) 0.00 = EBIT TTM 2.03b / Avg Total Assets 1587.67b
(D) 0.04 = Book Value of Equity 61.95b / Total Liabilities 1522.35b
Total Rating: -1.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 51.92

1. Piotroski 5.0pt = 0.0
2. FCF Yield 0.96% = 0.48
3. FCF Margin 10.66% = 2.66
4. Debt/Equity 9.90 = -2.50
5. Debt/Ebitda 92.39 = -2.50
6. ROIC - WACC (= -2.28)% = -2.86
7. RoE 9.56% = 0.80
8. Rev. Trend 66.68% = 5.00
9. EPS Trend 16.72% = 0.84

What is the price of BCS shares?

As of September 17, 2025, the stock is trading at USD 20.63 with a total of 7,275,194 shares traded.
Over the past week, the price has changed by +1.58%, over one month by +1.68%, over three months by +17.31% and over the past year by +78.63%.

Is Barclays a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Barclays is currently (September 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 51.92 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCS is around 26.94 USD . This means that BCS is currently undervalued and has a potential upside of +30.59% (Margin of Safety).

Is BCS a buy, sell or hold?

Barclays has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BCS.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the BCS price?

Issuer Target Up/Down from current
Wallstreet Target Price 19.9 -3.5%
Analysts Target Price 19.9 -3.5%
ValueRay Target Price 28.6 38.5%

Last update: 2025-09-11 04:32

BCS Fundamental Data Overview

Market Cap GBP = 52.33b (71.17b USD * 0.7352 USD.GBP)
CCE Cash And Equivalents = 225.72b GBP (Cash And Short Term Investments, last quarter)
P/E Trailing = 9.2318
P/E Forward = 7.2886
P/S = 2.7744
P/B = 0.6919
P/EG = 1.2788
Beta = 1.023
Revenue TTM = 51.97b GBP
EBIT TTM = 2.03b GBP
EBITDA TTM = 8.13b GBP
Long Term Debt = 117.44b GBP (from longTermDebt, last quarter)
Short Term Debt = 633.84b GBP (from totalCurrentLiabilities, last quarter)
Debt = 751.28b GBP (Calculated: Short Term 633.84b + Long Term 117.44b)
Net Debt = -108.28b GBP (from netDebt column, last quarter)
Enterprise Value = 577.88b GBP (52.33b + Debt 751.28b - CCE 225.72b)
Interest Coverage Ratio = 0.08 (Ebit TTM 2.03b / Interest Expense TTM 25.39b)
FCF Yield = 0.96% (FCF TTM 5.54b / Enterprise Value 577.88b)
FCF Margin = 10.66% (FCF TTM 5.54b / Revenue TTM 51.97b)
Net Margin = 13.50% (Net Income TTM 7.02b / Revenue TTM 51.97b)
Gross Margin = 51.14% ((Revenue TTM 51.97b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Tobins Q-Ratio = 9.33 (Enterprise Value 577.88b / Book Value Of Equity 61.95b)
Interest Expense / Debt = 3.38% (Interest Expense 25.39b / Debt 751.28b)
Taxrate = 21.61% (1.75b / 8.11b)
NOPAT = 1.59b (EBIT 2.03b * (1 - 21.61%))
Current Ratio = 0.36 (Total Current Assets 225.72b / Total Current Liabilities 633.84b)
Debt / Equity = 9.90 (Debt 751.28b / last Quarter total Stockholder Equity 75.91b)
Debt / EBITDA = 92.39 (Net Debt -108.28b / EBITDA 8.13b)
Debt / FCF = 135.6 (Debt 751.28b / FCF TTM 5.54b)
Total Stockholder Equity = 73.39b (last 4 quarters mean)
RoA = 0.44% (Net Income 7.02b, Total Assets 1598.70b )
RoE = 9.56% (Net Income TTM 7.02b / Total Stockholder Equity 73.39b)
RoCE = 1.06% (Ebit 2.03b / (Equity 73.39b + L.T.Debt 117.44b))
RoIC = 0.79% (NOPAT 1.59b / Invested Capital 201.71b)
WACC = 3.07% (E(52.33b)/V(803.61b) * Re(9.15%)) + (D(751.28b)/V(803.61b) * Rd(3.38%) * (1-Tc(0.22)))
Shares Correlation 3-Years: -64.62 | Cagr: -1.38%
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.61% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 7.82 (DCF Value 27.40b / Shares Outstanding 3.50b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 16.72 | EPS CAGR: 15.10% | SUE: 0.25 | # QB: 0
Revenue Correlation: 66.68 | Revenue CAGR: 50.84%

Additional Sources for BCS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle